Bioequivalence of Two Formulations of Meropenem Intravenous Injection

NCT02344563 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Meropem
DRUG: Mepem

Sponsor

Yung Shin Pharm. Ind. Co., Ltd.